Pages that link to "Q44476486"

The following pages link to Tolerance of ocular iontophoresis in healthy volunteers (Q44476486):

Displaying 26 items.

• Recent Advances in Ophthalmic Drug Delivery (Q34636338) (← links)
• Recent perspectives in ocular drug delivery (Q37256549) (← links)
• International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics. (Q37257730) (← links)
• Non-invasive gene transfer by iontophoresis for therapy of an inherited retinal degeneration (Q37268483) (← links)
• Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera. (Q37274226) (← links)
• Ophthalmic drug delivery: development and regulatory considerations. (Q37395756) (← links)
• New techniques for drug delivery to the posterior eye segment (Q37692245) (← links)
• Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals (Q37882685) (← links)
• Nanomaterials for ocular drug delivery (Q38003088) (← links)
• Topical delivery of ocular therapeutics: carrier systems and physical methods. (Q38196446) (← links)
• Assessment of trans-scleral iontophoresis delivery of lutein to the human retina (Q38658699) (← links)
• Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging (Q41434956) (← links)
• Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis (Q41856804) (← links)
• Examination of barriers and barrier alteration in transscleral iontophoresis. (Q41891987) (← links)
• Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI. (Q42245964) (← links)
• In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application (Q42925005) (← links)
• Transscleral passive and iontophoretic transport: theory and analysis. (Q45305545) (← links)
• Iontophoretic drug delivery using the IOMED Phoresor system (Q48754903) (← links)
• Methotrexate delivery to the eye using transscleral hydrogel iontophoresis (Q50913374) (← links)
• Ocular Drug Delivery. (Q51122641) (← links)
• Early effects of corneal collagen cross-linking by iontophoresis in ex vivo human corneas. (Q53007068) (← links)
• Iontophoretic Drug Delivery in the Oral Cavity (Q58796605) (← links)
• Enhanced transscleral lontophoretic transport with ion-exchange membrane (Q79908634) (← links)
• Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for Treating Noninfectious Anterior Uveitis (Q82671800) (← links)
• Contribution of inertial cavitation in the enhancement of in vitro transscleral drug delivery (Q87419475) (← links)
• Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules (Q90186280) (← links)